CMPX
CMPX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
8
$183K
Insider Sales
2
$11.36M
Total Volume
$11.54M
15 transactions
Net Activity
$11.17M
Net selling
Sentiment Rating
Moderate AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 98% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$72.19B total
Gordon Carl L
Dir, 10%
$5.68M total
Orbimed Advisors LLC
Dir, 10%
$5.68M total
Lerner Neil
CHIEF ACCOUNTING OFFICER
$84K total
Anderman Jonathan
GC
$78K total
Quick Actions
CMPX has an insider buy conviction of 2%, compared to the Unknown sector buy average of 6%. CMPX ranks #549 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at CMPX (CMPX) engaged in a total of 15 transactions reported via SEC Form 4 filings. Among these, 8 were open-market purchases and 2 were sales. The total volume of insider trading reached $11.54M.
The net insider activity for CMPX shows a net selling bias of $11.17M. This activity represents a 2% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 6.48M shares valued at $64.81B on May 27, 2025.
Compass Therapeutics Stock Price Forecast. Should You Buy CMPX?
CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing
Why Did Compass Therapeutics Stock Plunge Today? - Compass Therapeutics (NASDAQ:CMPX)
CMPX - Compass Therapeutics Inc Stock Price and Quote
CMPX Forecast — Price Target — Prediction for 2027
Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity (NASDAQ:CMPX)
FAQs About CMPX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CMPX.